Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Hainaut

Showing results (181-190 of 280) with videos related to

Pageof 28
Sort By:
Plos One|October 12, 2012
Increased oxidative damage in carriers of the germline TP53 p.R337H mutationGabriel S Macedo, Leonardo Lisbôa da Motta, Juliana Giacomazzi, et al.
Plos One|March 24, 2017
Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinomaReetta Holmila, Athena Sklias, David C Muller, et al.
BMC Cancer|December 19, 2012
Epidermal growth factor receptor (EGFR) mutations and expression in squamous cell carcinoma of the esophagus in central AsiaBehnoush Abedi-Ardekani, Nazir Ahmad Dar, Mohammad Muzaffar Mir, et al.
Journal of the National Cancer Institute|December 10, 2022
Reply to Evans and WoodwardChristian P Kratz, Dmitrii Smirnov, Robert Autry, et al.
Investigational New Drugs|May 20, 2014
PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell linesPatricia Izetti, Agnes Hautefeuille, Ana Lucia Abujamra, et al.
Journal of the National Cancer Institute|April 2, 2023
Reply to Li and ColleaguesChristian P Kratz, Dmitrii Smirnov, Robert Autry, et al.
Virchows Archiv : an International Journal of Pathology|February 17, 2010
The role of the pathologist in tissue banking: European Consensus Expert Group ReportGeneroso Bevilacqua, Fred Bosman, Thibaut Dassesse, et al.
Journal of the National Cancer Institute|August 18, 2022
Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With CancerChristian P Kratz, Dmitrii Smirnov, Robert Autry, et al.
International Journal of Molecular Sciences|June 2, 2021
<i>TP53</i> Targeted Deep Sequencing of Cell-Free DNA in Esophageal Squamous Cell Carcinoma Using Low-Quality Serum: Concordance with Tumor MutationDariush Nasrollahzadeh, Gholamreza Roshandel, Tiffany Myriam Delhomme, et al.
Genes, Chromosomes & Cancer|July 10, 2013
Association between TP53 R249S mutation and polymorphisms in TP53 intron 1 in hepatocellular carcinomaSandra Ortiz-Cuaran, David Cox, Stéphanie Villar, et al.
Pageof 28

Showing results (181-190 of 280) with videos related to

Sort By:
Pageof 28
Plos One|October 12, 2012
Increased oxidative damage in carriers of the germline TP53 p.R337H mutationGabriel S Macedo, Leonardo Lisbôa da Motta, Juliana Giacomazzi, et al.
Plos One|March 24, 2017
Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinomaReetta Holmila, Athena Sklias, David C Muller, et al.
BMC Cancer|December 19, 2012
Epidermal growth factor receptor (EGFR) mutations and expression in squamous cell carcinoma of the esophagus in central AsiaBehnoush Abedi-Ardekani, Nazir Ahmad Dar, Mohammad Muzaffar Mir, et al.
Journal of the National Cancer Institute|December 10, 2022
Reply to Evans and WoodwardChristian P Kratz, Dmitrii Smirnov, Robert Autry, et al.
Investigational New Drugs|May 20, 2014
PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell linesPatricia Izetti, Agnes Hautefeuille, Ana Lucia Abujamra, et al.
Journal of the National Cancer Institute|April 2, 2023
Reply to Li and ColleaguesChristian P Kratz, Dmitrii Smirnov, Robert Autry, et al.
Virchows Archiv : an International Journal of Pathology|February 17, 2010
The role of the pathologist in tissue banking: European Consensus Expert Group ReportGeneroso Bevilacqua, Fred Bosman, Thibaut Dassesse, et al.
Journal of the National Cancer Institute|August 18, 2022
Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With CancerChristian P Kratz, Dmitrii Smirnov, Robert Autry, et al.
International Journal of Molecular Sciences|June 2, 2021
<i>TP53</i> Targeted Deep Sequencing of Cell-Free DNA in Esophageal Squamous Cell Carcinoma Using Low-Quality Serum: Concordance with Tumor MutationDariush Nasrollahzadeh, Gholamreza Roshandel, Tiffany Myriam Delhomme, et al.
Genes, Chromosomes & Cancer|July 10, 2013
Association between TP53 R249S mutation and polymorphisms in TP53 intron 1 in hepatocellular carcinomaSandra Ortiz-Cuaran, David Cox, Stéphanie Villar, et al.
Pageof 28